allanore yannick

101 posts

allanore yannick

allanore yannick

@allanore

Rheumatologist at Cochin Hospital (head of rheumatology department) and researcher at Cochin Institute with special interest in systemic sclerosis

Paris, France Katılım Ekim 2011
33 Takip Edilen323 Takipçiler
allanore yannick
allanore yannick@allanore·
Skin score supervised by Pr Khanna at WSC
allanore yannick tweet media
English
0
0
2
48
allanore yannick
allanore yannick@allanore·
I’m honored to be speaking at the 9th World Congress on Systemic Sclerosis in Athens, from March 5–7, 2026: I’ll be presenting on Session 15 Therapy. Congress programme available online. Join me to explore the latest science and clinical advances in systemic sclerosis.
English
0
1
7
80
allanore yannick retweetledi
EUSTAR
EUSTAR@EUSTAR_org·
✨Congratulations to our YIG members that their #EUSTAR abstracts have been accepted for #EULAR2025 🎯@CorradoCampoch1:Evidence-based detection of progression of systemic sclerosis-interstitial lung disease patients: the EUSTAR-PPF study (CP number 148). 📌B2,11 June4:40 - 4.50pm
English
0
2
5
579
allanore yannick retweetledi
EUSTAR
EUSTAR@EUSTAR_org·
🔥#EUSTAR course, Bordeaux 2025 🔥 ✨3 briliant days full of #SSc brainstorming are behind us✨ ✨We are proud of all the participants! Thank you for the wonderful discussions and for being very motivated and passionate about #SSC!✨ 🎯Stay tuned with us!
EUSTAR tweet media
Bordeaux, France 🇫🇷 English
0
7
20
887
allanore yannick retweetledi
World Scleroderma Foundation
World Scleroderma Foundation@Worldsclerofnd·
⏳2 days to go! The EUSTAR Course 2025 kicks off in Bordeaux on Feb 6! 🔬✨oin top experts to explore the latest in SSc research, early diagnosis, ILD, PAH, GI challenges & more.📲 Stay tuned for live updates & expert insights! @EUSTAR_org #SSc #MedicalEducation
World Scleroderma Foundation tweet mediaWorld Scleroderma Foundation tweet mediaWorld Scleroderma Foundation tweet mediaWorld Scleroderma Foundation tweet media
English
0
2
7
451
allanore yannick retweetledi
Reumatologia Sant Pau-Dos de Maig
Reumatologia Sant Pau-Dos de Maig@reuma_santpau·
Arranquem amb el 2n dia del VII Curs de MAS de la @SCReuma! Comencem amb la conferència magistral del prof. Yanick Allanore @allanore de @HopitalCochin. Systemic Sclerosis: update in treatment recommendations. An honour to have you! Thank you for the outstanding lecture.
Reumatologia Sant Pau-Dos de Maig tweet mediaReumatologia Sant Pau-Dos de Maig tweet mediaReumatologia Sant Pau-Dos de Maig tweet mediaReumatologia Sant Pau-Dos de Maig tweet media
Català
0
3
11
460
allanore yannick
allanore yannick@allanore·
Results from the international collaborative systematic literature review informing the 2023 EULAR recommendations for the treatment of systemic sclerosis ard.bmj.com/content/early/…
English
1
0
7
154
allanore yannick retweetledi
Annals of the Rheumatic Diseases
Check out the latest update of @eular_org recommendations for #systemic #sclerosis treatment ▶️ 22 recommendations covering 8 clinical domains ▶️ new recommendations on treatments for skin fibrosis and lung disease ▶️ first- & second-line interventions 🔗 bit.ly/4h4nCzk
Annals of the Rheumatic Diseases tweet mediaAnnals of the Rheumatic Diseases tweet mediaAnnals of the Rheumatic Diseases tweet mediaAnnals of the Rheumatic Diseases tweet media
English
0
32
46
2.6K
allanore yannick
allanore yannick@allanore·
After a long but stimulating journey, the update in systemic sclerosis recommendations is available, enjoy the reading and a big thank to the outstanding task force doi.org/10.1136/ard-20…
English
0
12
35
1.6K
allanore yannick
allanore yannick@allanore·
the Fully updated third edition has reached > 10k accesses It Provides a concise synthesis of pathogenesis and modern approaches to management of systemic sclerosis It Presents an integrated multidisciplinary approach to comprehensive patient care
allanore yannick tweet media
English
1
9
59
3.2K
allanore yannick
allanore yannick@allanore·
Glad to attend the Brazilian Society in Belo Horizonte. Large audience today for discussions on the Update of the recommandations on systemic sclerosis. Insights are the availability of synthetic and biologic DMARDS, 3 drugs labelled in some countries!
English
0
1
3
140